Brief: Telomir Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Telomir Pharmaceuticals - SEC Filing
21/05/2025 23:42
Telomir Pharmaceuticals Inc TELO.O: TELOMIR PHARMACEUTICALS INC - MICHELLE YANEZ STEPS DOWN AS CFO OF TELOMIR PHARMACEUTICALS - SEC FILING TELOMIR PHARMACEUTICALS INC - APPOINTS ALAN WEICHSELBAUM AS CFO - SEC FILING Source text: [ID:n0001641172-25-011938] Further company coverage: TELO.O
Recent news on Telomir Pharmaceuticals
See all newsBrief: Telomir Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
Brief: Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality In Human Triple-Negative Breast Cancer Models
Brief: Telomir Pharmaceuticals Telomir-1 Significantly Reduced Tumor Growth And Metastases
Brief: Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer’S “Kill-And-Clean” Defense Systems In An Aggressive Prostate Cancer Model
U.S. STOCKS ON THE MOVE-InterDigital, Scholar Rock, Live Nation